Appili Therapeutics Inc.
APLIF
$0.0264
-$0.0018-6.38%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 94.20% | 42.01% | 36.71% | 25.26% | 24.92% |
| Total Depreciation and Amortization | 127.27% | 116.67% | 116.67% | -55.56% | -52.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -72.96% | -106.64% | -20.90% | -16.90% | -73.40% |
| Change in Net Operating Assets | -76.39% | 140.36% | 73.31% | 113.81% | 136.00% |
| Cash from Operations | 126.39% | 92.54% | 61.05% | 73.12% | 84.87% |
| Capital Expenditure | -- | -- | -- | -483.33% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | -862.07% | -916.67% | -100.00% |
| Total Debt Issued | -- | -- | -- | -44.44% | -- |
| Total Debt Repaid | -29.49% | 6.16% | -13.17% | 99.28% | 97.87% |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 13.17% | 12.74% | -102.99% | 1.14% | -102.17% |
| Cash from Financing | -8.36% | 357.10% | -97.33% | 90.37% | -100.74% |
| Foreign Exchange rate Adjustments | -109.09% | -95.24% | 104.72% | -102.55% | 105.70% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 120.71% | 96.11% | -66.33% | 135.93% | -51.33% |
